RDSNF (Redsense Medical AB) LT-Debt-to-Total-Asset: 0.00 (As of Mar. 2026)


RDSNF Redsense Medical AB RDSNF
55 GF Score
Price $0.51
GF Value $0.85
! 5 Warning Signs
View Full Analysis

What is Redsense Medical AB LT-Debt-to-Total-Asset?

Redsense Medical AB RDSNF -51.43% 55 LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus rates RDSNF with a GF Score™ of 55/100 and a GF Value™ of $0.85. The stock has 5 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Redsense Medical AB's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.00.

Redsense Medical AB's long-term debt to total assets ratio stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00).

Redsense Medical AB  (OTCPK:RDSNF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Redsense Medical AB LT-Debt-to-Total-Asset Related Terms

Redsense Medical AB LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Redsense Medical AB's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redsense Medical AB LT-Debt-to-Total-Asset Chart

Redsense Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.00 0.00 0.00 0.00

Redsense Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
RDSNF
55GF Score
Redsense Medical AB RDSNF
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Redsense Medical AB LT-Debt-to-Total-Asset Calculation

Redsense Medical AB's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=0/4.224
=0.00

Redsense Medical AB's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=0/4.249
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Redsense Medical AB (RDSNF) has a LT-Debt-to-Total-Asset of 0.00 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Redsense Medical AB and its competitors.
Is Redsense Medical AB's LT-Debt-to-Total-Asset too high?
Redsense Medical AB's current LT-Debt-to-Total-Asset is 0.00. Overall, Redsense Medical AB has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Redsense Medical AB's LT-Debt-to-Total-Asset compare to ABT and SYK?
Redsense Medical AB's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?
A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Redsense Medical AB and its competitors. Redsense Medical AB's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redsense Medical AB stock overvalued right now?
Redsense Medical AB (RDSNF) has a current LT-Debt-to-Total-Asset of 0.00. The stock's GF Value™ is $0.85, compared to a current price of $0.51 — trading 40% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.00. Redsense Medical AB's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Redsense Medical AB (RDSNF), the current LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Redsense Medical AB (RDSNF) Overvalued in 2026?

Based on GuruFocus' analysis, Redsense Medical AB stock appears to be undervalued. The current stock price of $0.51 is trading 40% below its estimated GF Value™ of $0.85.

Key valuation signals for RDSNF:

  • LT-Debt-to-Total-Asset: 0.00
  • GF Value™: $0.85 vs. price of $0.51 (40% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the RDSNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Redsense Medical AB Business Description

Other Exchanges REDS:Sweden
Address Storgatan 36, Halmstad, SWE, 302 43
Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.
55GF Score

Get the complete analysis for RDSNF

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.51
Price
$0.85
GF Value